Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Diplomat Pharmacy Inc (DPLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,066,410
  • Shares Outstanding, K 74,470
  • Annual Sales, $ 4,485 M
  • Annual Income, $ 15,510 K
  • 36-Month Beta 0.88
  • Price/Sales 0.24
  • Price/Cash Flow 7.99
  • Price/Book 1.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.22
  • Number of Estimates 8
  • High Estimate 0.26
  • Low Estimate 0.20
  • Prior Year 0.18
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.20 +0.85%
on 12/14/18
16.35 -12.42%
on 12/07/18
-1.18 (-7.61%)
since 11/14/18
3-Month
13.31 +7.59%
on 11/07/18
21.48 -33.33%
on 11/02/18
-4.29 (-23.05%)
since 09/14/18
52-Week
13.31 +7.59%
on 11/07/18
28.74 -50.17%
on 06/22/18
-5.50 (-27.75%)
since 12/14/17

Most Recent Stories

More News
Diplomat Selects Inovalon's Specialty Pharmacy Platform

Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year deal with Diplomat (NYSE: DPLO), the nation's...

INOV : 13.81 (-1.07%)
DPLO : 14.32 (-2.59%)
New Strong Sell Stocks for November 27th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

LBY : 5.09 (-9.91%)
TKAMY : 17.5850 (-2.36%)
TRTX : 19.50 (unch)
CL : 65.17 (-0.46%)
DPLO : 14.32 (-2.59%)
Diplomat Switches to Fully Recyclable Packaging for Temperature-Sensitive Medication

Diplomat Pharmacy, Inc. (NYSE: DPLO), is now shipping temperature-sensitive medication in ClimaCell(TM) coolers from TemperPack.

DPLO : 14.32 (-2.59%)
Radnet Inc is Among the Companies in the Health Care Services Industry with the Best Relative Performance (RDNT , DPLO , CVS , ESRX , MD )

We looked at the Health Care Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

CVS : 71.88 (-2.03%)
RDNT : 12.28 (-3.00%)
DPLO : 14.32 (-2.59%)
Top 5 Companies in the Health Care Services Industry with the Best Relative Performance (AMED , DPLO , MD , CVS , PINC )

Below are the top five companies in the Health Care Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

AMED : 124.24 (-4.14%)
MD : 36.25 (-3.41%)
DPLO : 14.32 (-2.59%)
Diplomat Pharmac has the Best Relative Performance in the Health Care Services Industry (DPLO , BEAT , CVS , AMED , MD )

We looked at the Health Care Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

CVS : 71.88 (-2.03%)
BEAT : 64.54 (-2.52%)
DPLO : 14.32 (-2.59%)
Shares of Cross Country He Rank the Highest in Terms of Relative Performance in the Health Care Services Industry (CCRN , AMED , DPLO , DGX , LH )

We looked at the Health Care Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

CCRN : 7.86 (-1.26%)
AMED : 124.24 (-4.14%)
DPLO : 14.32 (-2.59%)
Diplomat Pharmaceuticals (DPLO) Reports Break-Even Earnings for Q3

Diplomat Pharmaceuticals (DPLO) delivered earnings and revenue surprises of -100.00% and -4.69%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the...

DPLO : 14.32 (-2.59%)
Diplomat Pharmaceuticals: 3Q Earnings Snapshot

FLINT, Mich. (AP) _ Diplomat Pharmacy Inc. (DPLO) on Tuesday reported third-quarter net income of $169,000.

DPLO : 14.32 (-2.59%)
Diplomat Announces 3rd Quarter Financial Results

Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30, 2018. All comparisons, unless...

DPLO : 14.32 (-2.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade DPLO with:

Business Summary

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including...

See More

Key Turning Points

2nd Resistance Point 15.00
1st Resistance Point 14.66
Last Price 14.32
1st Support Level 14.09
2nd Support Level 13.86

See More

52-Week High 28.74
Fibonacci 61.8% 22.85
Fibonacci 50% 21.02
Fibonacci 38.2% 19.20
Last Price 14.32
52-Week Low 13.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar